Episode Details
Back to Episodes
A deep dive discussion on Abivax with Truist Senior Biotech Analyst Gregory Renza
Published 8 months, 2 weeks ago
Description
We discuss the upcoming maintenance data, commercial prospects, Crohn's, and buyout prospects.